Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

Untitled work

(1970) · Cited by 24,983 · see citing works

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.

Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378 · see citing works

Cognitive and emotional influences in anterior cingulate cortex

Bush, G., Luu, P., & Posner, M. I. (2000) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(00)01483-2 · Cited by 6,259 · see citing works

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients

McLellan, A. T., Luborsky, L. B., WOODY, G. E., & Brien, C. P. O. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,163 · see citing works

Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala

Adolphs, R., Tranel, D., Damasio, H., & Damasio, A. (1994) · Nature · doi:10.1038/372669a0 · Cited by 2,360 · see citing works

A differential neural response in the human amygdala to fearful and happy facial expressions

Morris, J. S., Frith, C. D., Perrett, D. I., Rowland, D., Young, A. W., Calder, A. J., & Dolan, R. J. (1996) · Nature · doi:10.1038/383812a0 · Cited by 2,013 · see citing works

The endogenous cannabinoid system controls extinction of aversive memories

Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728 · see citing works

Response and Habituation of the Human Amygdala during Visual Processing of Facial Expression

Breiter, H. C., Etcoff, N. L., Whalen, P. J., Kennedy, W. A., Rauch, S. L., Buckner, R. L., Strauss, M. M., Hyman, S. E., & Rosen, B. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80219-6 · Cited by 1,711 · see citing works

Conscious and unconscious emotional learning in the human amygdala

Morris, J. S., Öhman, A., & Dolan, R. J. (1998) · Nature · doi:10.1038/30976 · Cited by 1,665 · see citing works

A specific neural substrate for perceiving facial expressions of disgust

Phillips, M. L., Young, A. W., Senior, C., Brammer, M., Andrew, C., Calder, A. J., Bullmore, E. T., Perrett, D. I., Rowland, D., Williams, S. C. R., et al. (1997) · Nature · doi:10.1038/39051 · Cited by 1,609 · see citing works

Role of Endogenous Cannabinoids in Synaptic Signaling

Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,567 · see citing works

A subcortical pathway to the right amygdala mediating “unseen” fear

Morris, J. S., Öhman, A., & Dolan, R. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1680 · Cited by 1,349 · see citing works

Sample Size Tables for Clinical Studies

Machin, D., Campbell, M. J., Tan, S. B., & Tan, S. H. (2008) · Wiley eBooks · doi:10.1002/9781444300710 · Cited by 1,336 · see citing works

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315 · see citing works

A neuromodulatory role for the human amygdala in processing emotional facial expressions

Morris, J. (1998) · Brain · doi:10.1093/brain/121.1.47 · Cited by 1,291 · see citing works

Human neural systems for face recognition and social communication

Haxby, J. V., Hoffman, E. A., & Gobbini, M. I. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01330-0 · Cited by 1,287 · see citing works

Dissociable neural responses to facial expressions of sadness and anger

Blair, R. J. R., Morris, J. S., Frith, C. D., Perrett, D. I., & Dolan, R. J. (1999) · Brain · doi:10.1093/brain/122.5.883 · Cited by 1,212 · see citing works

The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis

D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024 · see citing works

Activation of the left amygdala to a cognitive representation of fear

Phelps, E. A., O'Connor, K. J., Gatenby, J. C., Gore, J. C., Grillon, C., & Davis, M. (2001) · Nature Neuroscience · doi:10.1038/86110 · Cited by 895 · see citing works

Agonistic properties of cannabidiol at 5-HT1a receptors

Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878 · see citing works

Pharmacology and effects of cannabis: A brief review

Ashton, C. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.101 · Cited by 868 · see citing works

Sequence of information processing for emotions based on the anatomic dialogue between prefrontal cortex and amygdala

Ghashghaei, H. T., Hilgetag, C. C., & Barbas, H. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.09.046 · Cited by 845 · see citing works

Neural responses to facial and vocal expressions of fear and disgust

Phillips, M. L., Young, A. W., Scott, S. K., Calder, A., Andrew, C., Giampietro, V., Williams, S., Bullmore, E. T., Brammer, M. J., & Gray, J. A. (1998) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1998.0506 · Cited by 817 · see citing works

How Many Subjects Constitute a Study?

Friston, K. J., Holmes, A. P., & Worsley, K. J. (1999) · NeuroImage · doi:10.1006/nimg.1999.0439 · Cited by 814 · see citing works

Adverse effects of cannabis

Hall, W., & Solowij, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05021-1 · Cited by 778 · see citing works

Neuroanatomical correlates of externally and internally generated human emotion

(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.7.918 · Cited by 711 · see citing works

A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder

Surguladze, S., Brammer, M. J., Keedwell, P., Giampietro, V., Young, A. W., Travis, M. J., Williams, S. C. R., & Phillips, M. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.028 · Cited by 633 · see citing works

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617 · see citing works

Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects

Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608 · see citing works

The acute effects of cannabinoids on memory in humans: a review

Ranganathan, M., & D’Souza, D. C. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0508-y · Cited by 517 · see citing works

Reliability, validity, and clinical application of the visual analogue mood scale

Folstein, M. F., & Luria, R. E. (1973) · Psychological Medicine · doi:10.1017/s0033291700054283 · Cited by 514 · see citing works

Cannabidiol: An Overview of Some Pharmacological Aspects

Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 511 · see citing works

Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression

Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511232103 · Cited by 497 · see citing works

Early onset cannabis use and psychosocial adjustment in young adults

Fergusson, D. M., & Horwood, L. J. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb03198.x · Cited by 493 · see citing works

Endocannabinoid system and stress and anxiety responses

VIVEROS, M., MARCO, E., & FILE, S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.029 · Cited by 485 · see citing works

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimarães, F. S. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000400001 · Cited by 402 · see citing works

Face perception is mediated by a distributed cortical network

Ishai, A., Schmidt, C. F., & Boesiger, P. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.05.027 · Cited by 393 · see citing works

Aversive gustatory stimulation activates limbic circuits in humans

Zald, D. H. (1998) · Brain · doi:10.1093/brain/121.6.1143 · Cited by 384 · see citing works

Antianxiety effect of cannabidiol in the elevated plus-maze

Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., & Zuardi, A. W. (1990) · Psychopharmacology · doi:10.1007/bf02244012 · Cited by 379 · see citing works

Effects of ipsapirone and cannabidiol on human experimental anxiety

Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700112 · Cited by 364 · see citing works

Activation of the amygdala and anterior cingulate during nonconscious processing of sad versus happy faces

Killgore, W., & Yurgelun-Todd, D. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.12.033 · Cited by 339 · see citing works

The role of the cerebellum in affect and psychosis

Schmahmann, J. D. (2000) · Journal of Neurolinguistics · doi:10.1016/s0911-6044(00)00011-7 · Cited by 326 · see citing works

Human Brain Mapping

(2006) · Human Brain Mapping · doi:10.1002/(issn)1097-0193 · Cited by 325 · see citing works

Cannabis, the mind and society: the hash realities

Murray, R. M., Morrison, P. D., Henquet, C., & Forti, M. D. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2253 · Cited by 319 · see citing works

A Role for the Macaque Anterior Cingulate Gyrus in Social Valuation

Rudebeck, P. H., Buckley, M. J., Walton, M. E., & Rushworth, M. F. S. (2006) · Science · doi:10.1126/science.1128197 · Cited by 312 · see citing works

The cerebellum and emotional experience

Turner, B. M., Paradiso, S., Marvel, C. L., Pierson, R., Boles Ponto, L. L., Hichwa, R. D., & Robinson, R. G. (2007) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2006.09.023 · Cited by 310 · see citing works

Effects of cannabidiol (CBD) on regional cerebral blood flow

Crippa, J. A. D. S., Zuardi, A. W., Garrido, G. E. J., Wichert-Ana, L., Guarnieri, R., Ferrari, L., Azevedo-Marques, P. M., Hallak, J. E. C., McGuire, P. K., & Busatto, G. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300340 · Cited by 307 · see citing works

Rates of Psychiatric Comorbidity Among U.S. Residents with Lifetime Cannabis Dependence

Agosti, V., Nunes, E. V., & LEVIN, F. R. (2002) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-120015873 · Cited by 306 · see citing works

Arousal Dissociates Amygdala and Hippocampal Fear Responses: Evidence from Simultaneous fMRI and Skin Conductance Recording

Williams, L. M., Phillips, M. L., Brammer, M. J., Skerrett, D., Lagopoulos, J., Rennie, C., Bahramali, H., Olivieri, G., David, A. S., Peduto, A., et al. (2001) · NeuroImage · doi:10.1006/nimg.2001.0904 · Cited by 300 · see citing works

An Experimental Study of Catechol-O-Methyltransferase Val158Met Moderation of Δ-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition

Henquet, C., Rosa, A., A, L. K. M., Papiol, S., Fañanás, L., Drukker, M., Ramaekers, J. G., & van Os, J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301197 · Cited by 299 · see citing works

Cannabinoids in Clinical Practice

Williamson, E. M., & Evans, F. J. (2000) · Drugs · doi:10.2165/00003495-200060060-00005 · Cited by 283 · see citing works

Trajectories of marijuana use from adolescence to young adulthood: Predictors and outcomes

Windle, M. T., & Wiesner, M. (2004) · Development and Psychopathology · doi:10.1017/s0954579404040118 · Cited by 278 · see citing works

Therapeutic aspects of cannabis and cannabinoids

Robson, P. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.2.107 · Cited by 265 · see citing works

Comparative Receptor Binding Analyses of Cannabinoid Agonists and Antagonists

Thomas, B. F., Gilliam, A. F., Burch, D. F., Roche, M. J., & Seltzman, H. H. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37365-3 · Cited by 242 · see citing works

Cerebellar role in fear-conditioning consolidation

Sacchetti, B., Baldi, E., Lorenzini, C. A., & Bucherelli, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112660399 · Cited by 233 · see citing works

The effect of cingulate lesions on social behaviour and emotion

Hadland, K. A., Rushworth, M. F. S., Gaffan, D., & Passingham, R. E. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(02)00325-1 · Cited by 225 · see citing works

The relevance of behavioural measures for functional-imaging studies of cognition

Wilkinson, D. T., & Halligan, P. W. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1302 · Cited by 222 · see citing works

Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol

Berrendero, F., & Maldonado, R. J. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1144-9 · Cited by 221 · see citing works

Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication

Volkow, N. D., Gillespie, H. K., Mullani, N. A., Tancredi, L., Grant, C., Valentine, A., & Hollister, L. E. (1996) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(96)02817-x · Cited by 219 · see citing works

A Double Dissociation of Ventromedial Prefrontal Cortical Responses to Sad and Happy Stimuli in Depressed and Healthy Individuals

Keedwell, P. A., Andrew, C., Williams, S. C. R., Brammer, M. J., & Phillips, M. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.035 · Cited by 218 · see citing works

Marijuana use motives: Concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers

Bonn‐Miller, M. O., Zvolensky, M. J., & Bernstein, A. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2006.03.018 · Cited by 208 · see citing works

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test

Moreira, F. A., Aguiar, D. C., & Guimarães, F. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.004 · Cited by 207 · see citing works

Long‐term cannabis use: characteristics of users in an Australian rural area

Reilly, D., Didcott, P., Swift, W., & Hall, W. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9368375.x · Cited by 204 · see citing works

Cannabis and cognitive dysfunction: Parallels with endophenotypes of schizophrenia?

Solowij, N., & Michie, P. T. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0705 · Cited by 201 · see citing works

Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats

Resstel, L. B. M., Joca, S. R. L., Moreira, F. A., Corrêa, F. M. A., & Guimarães, F. S. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.05.016 · Cited by 182 · see citing works

Complex pharmacology of natural cannabivoids: Evidence for partial agonist activity of Δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors

Petitet, F., Jeantaud, B., Reibaud, M., Impérato, A., & Dubroeucq, M. C. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00238-0 · Cited by 180 · see citing works

Criminal Behaviour and Mental Health

Schanda, H. (2006) · Criminal Behaviour and Mental Health · doi:10.1002/(issn)1471-2857 · Cited by 178 · see citing works

Psychotic symptom and cannabis relapse in recent-onset psychosis: Prospective study

Hides, L., Dawe, S., Kavanagh, D. J., & Young, R. M. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.014308 · Cited by 166 · see citing works

Amygdala and anterior cingulate cortex activation during affective startle modulation: a PET study of fear

Pissiota, A., Frans, Ö., Michelgård, Å., Appel, L., Långström, B., Flaten, M. A., & Fredrikson, M. G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02855.x · Cited by 165 · see citing works

Cannabinoid receptors

Munro, S. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)81598-7 · Cited by 154 · see citing works

Task-Independent Functional Brain Activity Correlation with Skin Conductance Changes: An fMRI Study

Patterson, J. (2002) · NeuroImage · doi:10.1006/nimg.2002.1306 · Cited by 153 · see citing works

Progress in Electrodermal Research

Roy, J.-C., Boucsein, W., Fowles, D. C., & Gruzelier, J. H. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2864-7 · Cited by 152 · see citing works

Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of Δ9-tetrahydrocannabinol in rats

Manzanares, J., Corchero, J., & Fuentes, J. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01756-4 · Cited by 152 · see citing works

Functional disconnections in the direct and indirect amygdala pathways for fear processing in schizophrenia

Das, P., Kemp, A. H., Flynn, G., Harris, A. W. F., Liddell, B. J., Whitford, T., Peduto, A. S., GORDON, E., & Williams, L. M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.023 · Cited by 150 · see citing works

Carrier-Mediated Uptake of the Endogenous Cannabinoid Anandamide in RBL-2H3 Cells

Rakhshan, F., Day, T. A., Blakely, R., & Barker, E. L. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35376-5 · Cited by 149 · see citing works

Brain Neuroimaging in Cannabis Use: A Review

Quickfall, J., & Crockford, D. N. (2006) · Journal of Neuropsychiatry · doi:10.1176/jnp.2006.18.3.318 · Cited by 143 · see citing works

Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance

Heishman, S. J., Stitzer, M. L., & Yingling, J. E. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90369-9 · Cited by 136 · see citing works

Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance

González, R. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9036-8 · Cited by 134 · see citing works

Psychiatric symptoms in male cannabis users not using other illicit drugs

Troisi, A., Pasini, A., Saracco, M., & Spalletta, G. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9344874.x · Cited by 133 · see citing works

Marijuana intoxication and brain activation in marijuana smokers

Mathew, R. J., Wilson, W. H., Coleman, R. E., Turkington, T. G., & DeGrado, T. R. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00195-1 · Cited by 129 · see citing works

Estimating WAIS-R IQ from the national adult reading test: A cross-validation

Willshire, D., Kinsella, G., & Prior, M. R. (1991) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639108401038 · Cited by 127 · see citing works

Who is Using Cannabis as a Medicine and Why: An Exploratory Study

Ogborne, A. C., Smart, R. G., Weber, T. R., & Timney, C. B. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400245 · Cited by 120 · see citing works

Reasons for Cannabis use in Psychosis

Schofield, D., Tennant, C. C., Nash, L. M., Degenhardt, L. J., Cornish, A., Hobbs, C., & Brennan, G. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01840.x · Cited by 117 · see citing works

Inhibition of Anandamide Amidase Activity in Mouse Brain Microsomes by Cannabinoids.

Watanabe, K., Kayano, Y., Matsunaga, T., Yamamoto, I., & Yoshimura, H. (1996) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.19.1109 · Cited by 116 · see citing works

5-HT1A receptors are involved in the anxiolytic effect of Δ9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague–Dawley rats

Braida, D., Limonta, V., Malabarba, L., Zani, A. D., & Sala, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.038 · Cited by 115 · see citing works

Social anxiety and problematic cannabis use: Evaluating the moderating role of stress reactivity and perceived coping

Buckner, J. D., Schmidt, N. B., Bobadilla, L., & Taylor, J. E. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.08.002 · Cited by 114 · see citing works

The marijuana withdrawal syndrome: Diagnosis and treatment

Haney, M. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0036-1 · Cited by 112 · see citing works

Regional cerebral blood flow and depersonalization after tetrahydrocannabinol adrninistration

Mathew, R. J., Wilson, W. H., Chiu, N., Turkington, T. G., DeGrado, T. R., & Coleman, R. E. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb10916.x · Cited by 110 · see citing works

Cerebellar activity and disturbed time sense after THC

Mathew, R. J., Wilson, W. H., Turkington, T. G., & Coleman, R. E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00375-8 · Cited by 108 · see citing works

Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population

Tournier, M., Sorbara, F., Gindre, C., Swendsen, J. D., & Verdoux, H. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00052-0 · Cited by 107 · see citing works

Anandamide hydrolysis: a new target for anti-anxiety drugs?

Gaetani, S., Cuomo, V., & Piomelli, D. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.09.005 · Cited by 102 · see citing works

Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample

Zvolensky, M. J., Bernstein, A., Sachs-Ericsson, N., Schmidt, N. B., Buckner, J. D., & Bonn-Miller, M. O. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.09.005 · Cited by 102 · see citing works

Cerebellar hypoactivity in frequent marijuana users

Block, R. I., OʼLeary, D. S., Hichwa, R. D., Augustinack, J. C., Ponto, L. L. B., Ghoneim, M. M., Arndt, S. V., Ehrhardt, J. C., Hurtig, R. R., Watkins, G. L., et al. (2000) · Neuroreport · doi:10.1097/00001756-200003200-00019 · Cited by 93 · see citing works

Cerebellar metabolic activation by delta-9-tetrahydrocannabinol in human brain: A study with positron emission tomography and 18F-2-Fluoro-2-deoxyglucose

Volkow, N. D., Gillespie, H. K., Mullani, N. A., Tancredi, L., Grant, C., Ivanović, M., & Hollister, L. E. (1991) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(91)90030-t · Cited by 91 · see citing works

Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography

Mathew, R. J., Wilson, W. H., Turkington, T. G., Hawk, T. C., Coleman, R. E., DeGrado, T. R., & Provenzale, J. (2002) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00069-0 · Cited by 91 · see citing works

Stout Guards of the Central Nervous System

Mechoulam, R., & Lichtman, A. H. (2003) · Science · doi:10.1126/science.1091256 · Cited by 67 · see citing works

Cortical and Hypothalamo-Limbic Control of Electrodermal Responses

Sequeira, H., & Roy, J.-C. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2864-7_8 · Cited by 60 · see citing works

Clinical and Physiological Effects of Stereotaxic Bilateral Amygdalotomy for Intractable Aggression

Lee, G. P., Bechara, A., Adolphs, R., Arena, J. G., Meador, K. J., Loring, D. W., & Smith, J. R. (1998) · Journal of Neuropsychiatry · doi:10.1176/jnp.10.4.413 · Cited by 59 · see citing works

Substance Use Disorder Comorbidity Among Inpatient Youths With Psychiatric Disorder

Swadi, H. S., & Bobier, C. (2003) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2003.01180.x · Cited by 46 · see citing works

Involvement of the human cerebellum in fear-conditioned potentiation of the acoustic startle response: a PET study

Frings, M., Maschke, M., Erichsen, M., Jentzen, W., ller, S. P. M., Kolb, F. P., Diener, H., & Timmann, D. (2002) · Neuroreport · doi:10.1097/00001756-200207190-00012 · Cited by 34 · see citing works

Co-Morbidity of Select Anxiety, Affective, and Psychotic Disorders with Cannabis Dependence in Southwest California Indians

Gilde, D. A., Lau, P., Dixon, M., Corey, L., Phillips, E., & Ehlers, C. L. (2006) · Journal of Addictive Diseases · doi:10.1300/j069v25n04_07 · Cited by 34 · see citing works

Adverse Mental Health Effects of Cannabis Use in Two Indigenous Communities in Arnhem Land, Northern Territory, Australia: Exploratory Study

CLOUGH, A. R., D'Abbs, P. H., Cairney, S. J., Gray, D. A., Maruff, P. T., Parker, R., & O'Reilly, B. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2005.01634.x · Cited by 31 · see citing works

Differences in Temperament, Character and Psychopathology among Subjects with Different Patterns of Cannabis Use

Spalletta, G., Bria, P., & Caltagirone, C. (2006) · Psychopathology · doi:10.1159/000096387 · Cited by 25 · see citing works

Cannabis dependence and mental health perception amongst people diverted by police after arrest for cannabis-related offending behaviour in Australia

Feeney, G. F. X., Connor, J. P., Young, R. M., Tucker, J., & McPherson, A. (2005) · Criminal Behaviour and Mental Health · doi:10.1002/cbm.26 · Cited by 24 · see citing works

Spontaneous network activity of cerebellar granule neurons: impairment by in vivo chronic cannabinoid administration

Ghozland, S. G., Aguado, F., Espinosa‐Parrilla, J. F., Soriano, E., & Maldonado, R. J. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02112.x · Cited by 14 · see citing works

Psychotic symptom and cannabis relapse in recent-onset sychosis

Hides, L. M., Dawe, S., Kavanagh, D. J., & Young, R. M. (2006) · Faculty of Health; Institute of Health and Biomedical Innovation · Cited by 1 · see citing works

Activation of Broca's area by syntactic processing under conditions of concurrent articulation

Caplan, D., Alpert, N., Waters, G., & Olivieri, A. (2000) · Human Brain Mapping · doi:10.1002/(sici)1097-0193(200002)9:2

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.

Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535 · see citing works

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Devinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras‐Aswad, D., Notcutt, W. G., et al. (2014) · Epilepsia · doi:10.1111/epi.12631 · Cited by 1,000 · see citing works

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.6 · Cited by 771 · see citing works

Cannabidiol as a Potential Treatment for Anxiety Disorders

Blessing, E., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 717 · see citing works

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680 · see citing works

Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history

Bonini, S. A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M., & Mastinu, A. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.09.004 · Cited by 712 · see citing works

An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies

Iffland, K., & Grotenhermen, F. (2017) · Cannabis & Cannabinoid Research · doi:10.1089/can.2016.0034 · Cited by 645 · see citing works

Safety and side effects of cannabidiol, a Cannabis sativa constituent

Machado Bergamaschi, M., Helena Costa Queiroz, R., Waldo Zuardi, A., & Alexandre S. Crippa, J. (2011) · Current Drug Safety · doi:10.2174/157488611798280924 · Cited by 558 · see citing works

Cannabis, a complex plant: different compounds and different effects on individuals

Atakan, Z. (2012) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312457586 · Cited by 547 · see citing works

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: A preliminary report

Crippa, J. A. S., Derenusson, G. N., Ferrari, T. B., Wichert-Ana, L., Duran, F. L., Martin-Santos, R., Simões, M. V., Bhattacharyya, S., Fusar-Poli, P., Atakan, Z., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379283 · Cited by 535 · see citing works

Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

McPartland, J. M., Duncan, M., Marzo, V. D., & Pertwee, R. G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12944 · Cited by 526 · see citing works

Cannabidiol Adverse Effects and Toxicity

Huestis, M. A., Solimini, R., Pichini, S., Pacifici, R., Carlier, J., & Busardò, F. P. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666190603171901 · Cited by 479 · see citing works

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

Zuardi, A. W. (2008) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462008000300015 · Cited by 421 · see citing works

Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings

Batalla, A., Bhattacharyya, S., Yücel, M., Fusar‐Poli, P., Crippa, J. A. S., Nogué, S., Torrens, M., Pujol, J., Farré, M., & Martín‐Santos, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055821 · Cited by 416 · see citing works

Cannabis and anxiety: a critical review of the evidence

Crippa, J. A., Zuardi, A. W., Martín‐Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar‐Poli, P. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1048 · Cited by 509 · see citing works

Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial

Hurd, Y. L., Spriggs, S. A., Alishayev, J., Winkel, G. H., Gurgov, K., Kudrich, C., Oprescu, A. M., & Salsitz, E. A. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101191 · Cited by 344 · see citing works

Phytocannabinoids as novel therapeutic agents in {CNS} disorders.

Hill, A. J., Williams, C. M., Whalley, B. J., & Stephens, G. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.002 · Cited by 312 · see citing works

Gone to Pot – A Review of the Association between Cannabis and Psychosis

Radhakrishnan, R., Wilkinson, S. T., & Dâ€TMSouza, D. C. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00054 · Cited by 313 · see citing works

Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex Differences

Crane, N. A., Schuster, R. M., Fusar‐Poli, P., & González, R. (2012) · Neuropsychology Review · doi:10.1007/s11065-012-9222-1 · Cited by 310 · see citing works

Translational investigation of the therapeutic potential of Cannabidiol (CBD): Toward a new age

Crippa, J. A., Guimarães, F. S., Campos, A. C., & Zuardi, A. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02009 · Cited by 308 · see citing works

Cannabidiol: pharmacology and therapeutic targets

Britch, S. C., Babalonis, S., & Walsh, S. L. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05712-8 · Cited by 307 · see citing works

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

García-Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Austrich-Olivares, A., Sala, F., & Manzanares, J. (2020) · Biomolecules · doi:10.3390/biom10111575 · Cited by 306 · see citing works

Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy

Ujváry, I., & Hanuš, L. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2015.0012 · Cited by 302 · see citing works

Spicing things up: synthetic cannabinoids

Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3188-4 · Cited by 297 · see citing works

Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers

Martín‐Santos, R., Crippa, J. A. S., Batalla, A., Bhattacharyya, S., Atakan, Z., Borgwardt, S., Allen, P., Seal, M. L., Langohr, K., Farré, M., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884780 · Cited by 298 · see citing works

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life

Zuardi, A. W., Rodrigues, N. P., Silva, A. L., Bernardo, S. A., Hallak, J. E. C., Guimarães, F. S., & Crippa, J. A. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00259 · Cited by 294 · see citing works

Neuroimaging predictors of transition to psychosis—A systematic review and meta-analysis

Smieskova, R., Fusar‐Poli, P., Allen, P., Bendfeldt, K., Stieglitz, R. D., Drewe, J., Radue, E. W., McGuire, P. K., Riecher‐Rössler, A., & Borgwardt, S. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.016 · Cited by 294 · see citing works

Medical Use of Cannabinoids

Fraguas‐Sánchez, A. I., & Torres‐Suárez, A. I. (2018) · Drugs · doi:10.1007/s40265-018-0996-1 · Cited by 271 · see citing works

A systematic review of the antipsychotic properties of cannabidiol in humans

Iseger, T. A., & Bossong, M. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.033 · Cited by 261 · see citing works

Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial

Schaub, A.-C., Schneider, E., Vázquez-Castellanos, J. F., Schweinfurth, N., Kettelhack, C., Doll, J. P. K., Yamanbaeva, G., Mählmann, L., Brand, S., Beglinger, C., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01977-z · Cited by 273 · see citing works

Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test

Linares, I. M., Zuardi, A. W., Pereira, L. C., Queiroz, R. H., Mechoulam, R., Guimarães, F. S., & Crippa, J. A. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2017-0015 · Cited by 241 · see citing works

Does Cannabidiol Protect Against Adverse Psychological Effects of THC?

Niesink, R. J. M., & van Laar, M. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00130 · Cited by 241 · see citing works

Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol

Boggs, D. L., Nguyen, J. D., Morgenson, D., Taffe, M. A., & Ranganathan, M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.209 · Cited by 236 · see citing works

The neuropsychopharmacology of cannabis: A review of human imaging studies

Bloomfield, M., Hindocha, C., Green, S. F., Wall, M. B., Lees, R., Petrilli, K., Costello, H., Ogunbiyi, O., Bossong, M. G., & Freeman, T. P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.006 · Cited by 238 · see citing works

Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis

Hindley, G., Beck, K., Borgan, F., Ginestet, C. E., McCutcheon, R. A., Kleinloog, D., Ganesh, S., Radhakrishnan, R., D’Souza, D. C., & Howes, O. D. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30074-2 · Cited by 229 · see citing works

A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation

Waldo Zuardi, A., Alexandre S. Crippa, J., E.C. Hallak, J., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., K. McGuire, P., & Silveira Guimaraes, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884681 · Cited by 222 · see citing works

Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.

Haney, M., Malcolm, R. J., Babalonis, S., Nuzzo, P. A., Cooper, Z. D., Bedi, G., Gray, K. M., McRae-Clark, A., Lofwall, M. R., Sparenborg, S., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.367 · Cited by 206 · see citing works

Review of the neurological benefits of phytocannabinoids

Maroon, J. C., & Bost, J. (2018) · Surgical Neurology International · doi:10.4103/sni.sni_45_18 · Cited by 208 · see citing works

Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

Bhattacharyya, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.161 · Cited by 203 · see citing works

Neuroimaging in cannabis use: a systematic review of the literature

Martín‐Santos, R., Fagundo, A. B., Crippa, J. A. S., Atakan, Z., Bhattacharyya, S., Allen, P., Fusar‐Poli, P., Borgwardt, S., Seal, M. L., Busatto, G. F., et al. (2009) · Psychological Medicine · doi:10.1017/s0033291709990729 · Cited by 204 · see citing works

Cannabis-associated psychosis: Neural substrate and clinical impact

Murray, R. M., Englund, A., Abi‐Dargham, A., Lewis, D. A., Forti, M. D., Davies, C., Sherif, M. A., McGuire, P. K., & D’Souza, D. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.018 · Cited by 201 · see citing works

Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19

Jiang, R., Yamaori, S., Okamoto, Y., Yamamoto, I., & Watanabe, K. (2013) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-12-rg-129 · Cited by 199 · see citing works

Cannabidiol in Humans—The Quest for Therapeutic Targets

Zhornitsky, S., & Potvin, S. (2012) · Pharmaceuticals · doi:10.3390/ph5050529 · Cited by 199 · see citing works

Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users

Hindocha, C., Freeman, T. P., Schäfer, G., Gardener, C., Das, R., Morgan, C. J. A., & Curran, H. V. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.014 · Cited by 183 · see citing works

Medicinal use of cannabis in the United States: Historical perspectives, current trends, and future directions

Aggarwal, S. K., Carter, G. T., Sullivan, M. D., ZumBrunnen, C., Morrill, R. L., & Mayer, J. D. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0016 · Cited by 183 · see citing works

Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders

Campos, A. C., Fogaça, M. V., Scarante, F. F., Joca, S. R. L., Sales, A. J., Gomes, F. V., Sonego, A. B., Rodrigues, N. S., Galve-Roperh, I., & Guimarães, F. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00269 · Cited by 175 · see citing works

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors

Gomes, F. V., Resstel, L. B. M., & Guimarães, F. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2036-z · Cited by 174 · see citing works

Orbitofrontal Volumes in Early Adolescence Predict Initiation of Cannabis Use: A 4-Year Longitudinal and Prospective Study

Cheetham, A., Allen, N. B., Whittle, S., Simmons, J. G., Yücel, M., & Lubman, D. I. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.029 · Cited by 169 · see citing works

Cannabidiol (CBD) use in psychiatric disorders: A systematic review

Bonaccorso, S., Ricciardi, A., Zangani, C., Chiappini, S., & Schifano, F. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.002 · Cited by 170 · see citing works

Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage

Hurd, Y. L., Yoon, M. J., Manini, A. F., Hernandez, S. H., Olmedo, R., Östman, M., & Jutras‐Aswad, D. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0373-7 · Cited by 167 · see citing works

Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol

Fusar-Poli, P., Allen, P., Bhattacharyya, S., Crippa, J. A., Mechelli, A., Borgwardt, S., Martin-Santos, R., Seal, M. L., O'Carrol, C., Atakan, Z., et al. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990617 · Cited by 163 · see citing works

Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility

du Plessis, S. S., Agarwal, A. K., & Syriac, A. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0553-8 · Cited by 161 · see citing works

Considering Cannabis: The Effects of Regular Cannabis Use on Neurocognition in Adolescents and Young Adults

Lisdahl, K. M., Wright, N. E., Medina-Kirchner, C., Maple, K. E., & Shollenbarger, S. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0019-6 · Cited by 160 · see citing works

Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa

Schier, A. R. D. M., Ribeiro, N. D. C. R., Coutinho, D. C. O., Machado, S. E. D. C., Arias-Carrión, Ó., Crippa, J. A. S., Zuardi, A. W., Nardi, A. E., & Silva, A. R. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140612114838 · Cited by 154 · see citing works

Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug

Schier, A. R. D. M., Ribeiro, N. P. D. O., Silva, A. C. D. O. E., Hallak, J. E. C., Crippa, J. A. S., Nardi, A. E., & Zuardi, A. W. (2012) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462012000500008 · Cited by 154 · see citing works

The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease

Kicman, A., & Toczek, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186740 · Cited by 154 · see citing works

Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study

Winton-Brown, T. T., Allen, P., Bhattacharrya, S., Borgwardt, S. J., Fusar-Poli, P., Crippa, J. A., Seal, M. L., Martin-Santos, R., Ffytche, D., Zuardi, A. W., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.17 · Cited by 146 · see citing works

Cannabinoid modulation of prefrontal–limbic activation during fear extinction learning and recall in humans

Rabinak, C. A., Angstadt, M., Lyons, M., Mori, S., Milad, M. R., Liberzon, I., & Phan, K. L. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.09.009 · Cited by 148 · see citing works

Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety‐related and substance abuse disorders

Lee, J. L. C., Bertoglio, L. J., Guimarães, F. S., & Stevenson, C. W. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13724 · Cited by 140 · see citing works

Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use

González-Pinto, A. M., Alberich, S., Barbeito, S., Gutiérrez, M., Vega, P., Ibáñez, B., Haidar, K., Vieta, E., & Arango, C. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp126 · Cited by 140 · see citing works

Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors

Campos, A. C., Ferreira, F. R., & Guimarães, F. S. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.012 · Cited by 139 · see citing works

Gender effects on amygdala morphometry in adolescent marijuana users

McQueeny, T. M., Padula, C. B., Price, J. S., Lisdahl, K. M., Logan, P., & Tapert, S. F. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.031 · Cited by 139 · see citing works

Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects

Marco, E. M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00063 · Cited by 136 · see citing works

A naturalistic examination of the perceived effects of cannabis on negative affect

Cuttler, C., Spradlin, A., & McLaughlin, R. J. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.054 · Cited by 136 · see citing works

Use of cannabidiol in anxiety and anxiety-related disorders

Skelley, J. W., Deas, C. M., Curren, Z., & Ennis, J. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.11.008 · Cited by 137 · see citing works

Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence

Prud'homme, M., Cata, R., & Jutras‐Aswad, D. (2015) · Substance Abuse Research and Treatment · doi:10.4137/sart.s25081 · Cited by 133 · see citing works

Heavy cannabis use, dependence and the brain: a clinical perspective

Kroon, E., Kuhns, L., Hoch, E., & Cousijn, J. (2019) · Addiction · doi:10.1111/add.14776 · Cited by 130 · see citing works

Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties

Sharpe, L., Sinclair, J., Kramer, A., de Manincor, M., & Sarris, J. J. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02518-2 · Cited by 129 · see citing works

Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans

Manini, A. F., Yiannoulos, G., Bergamaschi, M. M., Hernandez, S. H., Olmedo, R., Barnes, A. J., Winkel, G. H., Sinha, R., Jutras‐Aswad, D., Huestis, M. A., et al. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000118 · Cited by 127 · see citing works

A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study

Jadoon, K. A., Tan, G. D., & O’Sullivan, S. E. (2017) · JCI Insight · doi:10.1172/jci.insight.93760 · Cited by 127 · see citing works

The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder

Chye, Y., Christensen, E., Solowij, N., & Yücel, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00063 · Cited by 128 · see citing works

Acute Effects of Heroin on Negative Emotional Processing: Relation of Amygdala Activity and Stress-Related Responses

Schmidt, A., Borgwardt, S., Gerber, H., Wiesbeck, G. A., Schmid, O., Riecher‐Rössler, A., Smieskova, R., Lang, U. E., & Walter, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.019 · Cited by 126 · see citing works

Human Laboratory Studies on Cannabinoids and Psychosis

Sherif, M. A., Radhakrishnan, R., D’Souza, D. C., & Ranganathan, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.011 · Cited by 122 · see citing works

Mitigation of post‐traumatic stress symptoms by <i>Cannabis</i> resin: A review of the clinical and neurobiological evidence

Passie, T., Emrich, H. M., Karst, M., Brandt, S. D., & Halpern, J. H. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1377 · Cited by 117 · see citing works

Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience

Bhattacharyya, S., Falkenberg, I., Martín‐Santos, R., Atakan, Z., Crippa, J. A. S., Giampietro, V., Brammer, M. J., & McGuire, P. K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.258 · Cited by 112 · see citing works

Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors

Soares, V. D. P., Campos, A. C., Bortoli, V. C. D., Zangrossi, H., Guimarães, F. S., & Zuardi, A. W. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.05.004 · Cited by 112 · see citing works

Marijuana: Current Concepts†

Greydanus, D. E., Hawver, E. K., Greydanus, M. M., & Merrick, J. (2013) · Frontiers in Public Health · doi:10.3389/fpubh.2013.00042 · Cited by 112 · see citing works

The effect of cannabis use on memory function: an update

Bhattacharyya, S., & Schoeler, T. (2013) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s25869 · Cited by 112 · see citing works

Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm

Uribe-Mariño, A., Biagioni, A. F., Castiblanco-Urbina, M. A., Twardowschy, A., Salgado-Rohner, C. J., Crippa, J. A. S., Hallak, J. E. C., Zuardi, A. W., & Coimbra, N. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.188 · Cited by 111 · see citing works

Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal

Hindocha, C., Freeman, T. P., Grabski, M., Stroud, J., Crudgington, H., Davies, A. C., Das, R., Lawn, W., Morgan, C. J. A., & Curran, H. V. (2018) · Addiction · doi:10.1111/add.14243 · Cited by 107 · see citing works

A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products

Meng, Q., Buchanan, B., Zuccolo, J., Poulin, M.-M., Gabriele, J. P., & Baranowski, D. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196396 · Cited by 107 · see citing works

The short-term and long-term effects of cannabis on cognition: recent advances in the field

Kroon, E., Kuhns, L., & Cousijn, J. (2020) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2020.07.005 · Cited by 107 · see citing works

Is cannabis neurotoxic for the healthy brain? A meta‐analytical review of structural brain alterations in non‐psychotic users

Rocchetti, M., Crescini, A., Borgwardt, S., Caverzasi, E., Politi, P., Atakan, Z., & Fusar‐Poli, P. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12085 · Cited by 103 · see citing works

Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview

Kumar, P., Mahato, D. K., Kamle, M., Borah, R., Sharma, B., Pandhi, S., Tripathi, V. S., Yadav, H. S., Devi, S., Patil, U., et al. (2021) · Phytotherapy Research · doi:10.1002/ptr.7213 · Cited by 108 · see citing works

Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice

Long, L. E., Chesworth, R., Huang, X., Wong, A., Spiro, A. S., McGregor, I. S., Arnold, J. C., & Karl, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034129 · Cited by 102 · see citing works

Cannabidiol for the treatment of <i>cannabis</i> withdrawal syndrome: a case report: CBD and cannabis withdrawal

Crippa, J. A. S., Hallak, J. E. C., Machado-de-Sousa, J. P., Queiroz, R. H. C., Bergamaschi, M., Chagas, M. H. N., & Zuardi, A. W. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12018 · Cited by 101 · see citing works

Cannabinoid Regulation of Fear and Anxiety: an Update

Papagianni, E. P., & Stevenson, C. W. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1026-z · Cited by 100 · see citing works

Affect and cannabis use in daily life: a review and recommendations for future research

Wycoff, A. M., Metrik, J., & Trull, T. J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.07.001 · Cited by 100 · see citing works

Cannabidiol as a potential treatment for psychosis

Schubart, C. D., Sommer, I. E., Fusar‐Poli, P., de Witte, L. D., Kahn, R. S., & Boks, M. P. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.002 · Cited by 100 · see citing works

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Linares, I. M. P., Guimarães, F. S., Éckeli, Á. L., Crippa, A. C. S., Zuardi, A. W., Souza, J. D. S., Hallak, J. E. C., & Crippa, J. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00315 · Cited by 99 · see citing works

Scientific Opinion on the risks for human health related to the presence of tetrahydrocannabinol (THC) in milk and other food of animal origin

(CONTAM), E. P. O. C. I. T. F. C. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4141 · Cited by 98 · see citing works

Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT _1A receptors

Gomes, F. V., Reis, D. G., Alves, F. H., Corrêa, F. M., Guimarães, F. S., & Resstel, L. B. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881110389095 · Cited by 97 · see citing works

The cannabinoid system and microglia in health and disease

Duffy, S. S., Hayes, J. P., Fiore, N. T., & Moalem‐Taylor, G. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108555 · Cited by 96 · see citing works

The Association between Regular Cannabis Exposure and Alterations of Human Brain Morphology: An Updated Review of the Literature

Lorenzetti, V., Solowij, N., Fornito, A., Lubman, D. I., & Yücel, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990435 · Cited by 96 · see citing works

A Systematic Review and Meta-Analysis of the Haemodynamic Effects of Cannabidiol

Sultan, S. R., Millar, S. A., England, T. J., & O'Sullivan, S. E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00081 · Cited by 95 · see citing works

Effects of Cannabis on Impulsivity: A Systematic Review of Neuroimaging Findings

Wrege, J. S., Schmidt, A., Walter, A., Smieskova, R., Bendfeldt, K., Radue, E. W., Lang, U. E., & Borgwardt, S. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990428 · Cited by 94 · see citing works

Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence

Rohleder, C., Müller, J. K., Lange, B., & Leweke, F. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00422 · Cited by 94 · see citing works

Cannabidiol (CBD) in Cancer Management

O’Brien, K. (2022) · Cancers · doi:10.3390/cancers14040885 · Cited by 90 · see citing works

Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review

Batalla, A., Crippa, J. A., Busatto, G. F., Guimaraes, F. S., Zuardi, A. W., Valverde, O., Atakan, Z., McGuire, P. K., Bhattacharyya, S., & Martín-Santos, R. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990432 · Cited by 91 · see citing works

Modulatory effects of cannabinoids on brain neurotransmission

Cohen, K., Weizman, A., & Weinstein, A. M. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14407 · Cited by 92 · see citing works

Distinct Effects of D9-tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

Fusar‐Poli, P. (2009) · European Psychiatry · doi:10.1016/s0924-9338(09)70439-0 · Cited by 11 · see citing works

ORIGINAL ARTICLE Distinct Effects of 9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

(2015)

Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol

Fusar-Poli, P., Allen, P., Bhattacharyya, S., Crippa, J. A., Mechelli, A., Borgwardt, S., Martin-Santos, R., Seal, M. L., O'Carrol, C., Atakan, Z., et al. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990617 · Cited by 163 · see citing works

Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors

Bhattacharyya, S., Egerton, A., Kim, E., Rosso, L., Barros, D. A. R., Hammers, A., Brammer, M. J., Turkheimer, F., Howes, O. D., & McGuire, P. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-14203-4 · Cited by 73 · see citing works

Opposite Neural Effects of the Main Psychoactive Ingredients of Cannabis- Neural Basis for Potential Therapeutic Effects of Cannabidiol

Bhattacharyya, S., Fusar‐Poli, P., Borgwardt, S., Martín‐Santos, R., Camille, C., Seal, M. L., Crippa, J. A. S., Atakan, Z., & McGuire, P. K. (2009) · European Psychiatry · doi:10.1016/s0924-9338(09)70924-1